Bella Aurora Labs, with more than 130 years of experience in the study of melanocyte behaviour, will participate in the Spanish National Congress of Dermatology and Venereology to be held in Bilbao on 1, 2 and 3 December.

Repigment12, a cosmetic treatment that eliminates white patches on the skin, is the result of many years of close collaboration between Dr Matteo Bordignon, an Italian dermatologist specialising in vitiligo, and Bella Aurora Labs, and will be presented to the over 1,600 dermatologists attending the Congress.

On 2 December at 5.15pm, the Satellite Symposium "MIA Inhibitors Technology: new alternative for the management of vitiligo" organised by Bella Aurora Labs will take place, attended by specialists such as Dr Matteo Bordignon, who will explain the results of his 10 years of research on this skin condition, and Dr López Estebaranz, from H.U. Fundación Alcorcón, who will give a presentation on patients with vitiligo.

Other participants include Marta Bajona, Medical Advisor of Bella Aurora Labs and the Association of Vitiligo Patients (ASPAVIT).

In addition, during the three day Congress, Bella Aurora Labs will have a stand to explain to all attendees their latest advancements in research.

More information about the Simposium: https://programa.congresoaedv.net/sesiones/910